Kestrel

Next Generation Sequencing Testing (NGS)

NHS Blood and Transplant · published Mon 26 Oct 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

The documents are on Atamis, where the bid is sent too. It's free to register there.

The notice as published

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.